Craft

Anaveon

Total Funding

$35 M

Anaveon Summary

Company Summary

Overview
Anaveon is a company that develops IL-2 complexes that promote effector T cell functions. Its compounds act as immune adjuvants with a broad therapeutic window and preclinical efficacy against cancer either as monotherapy or in combination with other therapies.
Type
Private
Status
Active
Founded
2017
HQ
Basel, CH | view all locations
Website
https://anaveon.com/
Cybersecurity rating
Sectors

Key People

  • Christoph Bucher

    Christoph Bucher, Chief Medical Officer

    • Allison Jeynes-Ellis

      Allison Jeynes-Ellis, Non-Executive Director

      • Christoph Huber

        Christoph Huber, Chief Scientific Officer

        • Christine Wurz

          Christine Wurz, Quality Assurance Director

          LocationsView all

          1 location detected

          • Basel, BS HQ

            Switzerland

            Hochbergerstrasse 60C

          Footer menu